HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases

American Journal of Hematology

Volumn 83, Issue 10, 2008, Pages 804-809

  Castillo, Jorge ^a,d   Pantanowitz, Liron ^b   Dezube, Bruce J ^c  

^a BROWN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CELL MARKER; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; STEROID; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CD4 LYMPHOCYTE COUNT; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GASTROINTESTINAL TRACT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; OVERALL SURVIVAL; PLASMA CELL; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT OUTCOME; TUMOR LOCALIZATION; VIRUS LOAD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; PREDNISONE; SURVIVAL ANALYSIS; VINCRISTINE; VIRAL LOAD;

EID: 53549113064     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21250     Document Type: Article

References (51)

1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413-1420.
2. Armstrong R, Bradrick J, Liu YC. Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: A case report. J Oral Maxillofac Surg 2007;65:1361-1364.
3. Assanasen T, Wannakrairot P, Keelawat S, et al. Extranodal malignant lymphoma of the upper aerodigestive tract: Prevalence of Epstien-Barr virus (EBV) infection in King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2005;88 (Suppl 4):S266-S273.
4. Borrero JJ, Pujol E, Perez S, et al. Plasmablastic lymphoma of the oral cavity and jaws. AIDS 2002;16:1979-1980.
5. Brown RS, Campbell C, Lishman SC, et al. Plasmablastic lymphoma: A new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma. Clin Oncol (R Coll Radiol) 1998;10:327-329.
6. Brown RS, Power DA, Spittle HF, et al. Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man. Clin Oncol (R Coll Radiol) 2000;12:194.
7. Chen YB, Yu H, Gillani A, et al. AIDS-associated plasmablastic lymphoma presenting at the insertion site of a peritoneal dialysis catheter. J Clin Oncol 2007;25:3176-3178.
8. Dawson MA, Schwerer AP, McLean C, et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation-treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica 2007;92:e11-e12.
9. Desai RS, Vanaki SS, Puranik RS, et al. Plasmablastic lymphoma presenting as a gingival growth in a previously undiagnosed HIV-positive patient: A case report. J Oral Maxillofac Surg 2007;65:1358-1361.
10. Flaitz CM, Nichols CM, Walling DM, et al. Plasmablastic lymphoma: An HIV-associated entity with primary oral manifestations. Oral Oncol 2002;38:96-102.
11. Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: An unrecognized cutaneous manifestation. Dermatology 2004;208:287-290.
12. Jordan LB, Lessells AM, Goodlad JR. Plasmablastic lymphoma arising at a cutaneous site. Histopathology 2005;46:113-115.
13. Lester R, Li C, Phillips P, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: A report of two cases. Leuk Lymphoma 2004;45:1881-1885.
14. Lin Y, Rodrigues GD, Turner JF, et al. Plasmablastic lymphoma of the lung: Report of a unique case and review of the literature. Arch Pathol Lab Med 2001;125:282-285.
15. Panos G, Karveli EA, Nikolatou O, et al. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol 2007;82:761-765.
16. Pantanowitz L, Doweiko JP, Braza J, et al. HIV-associated plasmablastic lymphoma following HAART-related immune reconstitution. HIV AIDS Rev 2007;7:29-32.
17. Porter SR, Diz Dios P, Kumar N, et al. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:730-734.
18. Radhakrishnan R, Suhas S, Kumar RV, et al. Plasmablastic lymphoma of the oral cavity in an HIV-positive child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:725-731.
19. Rajagopal AS, Copson E, Addis B, et al. Plasmablastic lymphoma: A case of rectal disease with spinal cord compression. Leuk Lymphoma. 2006;47:2670-2673.
20. Schichman SA, McClure R, Schaefer RF, et al. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: A further expansion of the disease spectrum. Am J Hematol 2004;77:291-295.
21. Sharma R, Abdou S, Plymyer MR, et al. Disseminated plasmablastic lymphoma. J Am Coll Surg 2004;199:654-655.
22. Shuangshoti S, Assanasen T, Lerdlum S, et al. Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol 2008:34:245-247.
23. Tavora F, Gonzalez-Cuyar LF, Sun CC, et al. Extra-oral plasmablastic lymphoma: Report of a case and review of literature. Hum Pathol 2006;37:1233-1236.
24. Cattaneo C, Facchetti F, Re A, et al. Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma. 2005;46:77-81.
25. Chetty R, Hlatswayo N, Muc R, et al. Plasmablastic lymphoma in HIV+ patients: An expanding spectrum. Histopathology 2003;42:605-609.
26. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004;28:736-747.
27. Ferrazzo KL, Mesquita RA, Aburad AT, et al. EBV detection in HIV-related oral plasmablastic lymphoma. Oral Dis 2007;13:564-569.
28. Folk GS, Abbondanzo SL, Childers EL, et al. Plasmablastic lymphoma: A clinicopathologic correlation. Ann Diagn Pathol 2006;10:8-12.
29. Lin O, Gerhard R, Zerbini MC, et al. Cytologic features of plasmablastic lymphoma. Cancer 2005;105:139-144.
30. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: A clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004;15:1673-1679.
31. Jaffe EHN, Stein H, Vardiman J. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
32. Carbone A, Gaidano G, Gloghini A, et al. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: A diagnostic dilemma. Ann Otol Rhinol Laryngol 1999;108:95-99.
33. Teruya-Feldstein J. Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr Oncol Rep 2005;7:357-363.
34. Miles RR, Raphael M, McCarthy K, et al. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatr Blood Cancer, E-pub ahead of print.
35. Pantanowitz L, Dezube BJ. Editorial comment: Plasmablastic lymphoma - A diagnostic and therapeutic puzzle. AIDS Read 2007;17:448-449.
36. Raez L, Cabral L, Cai JP, et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 1999;15:713-719.
37. Aboulafia DM, Ratner L, Miles SA, et al. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019. Clin Lymphoma Myeloma 2006;6:399-402.
38. Goedhals J, Beukes CA, Hardie D. HHV8 in plasmablastic lymphoma. Am J Surg Pathol 2008;32:172; author reply172-174.
39. Carbone A, Gloghini A, Gaidano G. Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004;28:1251-1252.
40. Jaffar SA, Pihan G, Dezube BJ, et al. Differentiating HIV-associated lymphomas that exhibit plasmacellular differentiation. HIV AIDS Rev 2005;4:43-49.
41. Lee OJ, Kim KW, Lee GK. Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma. J Oral Pathol Med 2006;35:382-384.
42. Borenstein J, Pezzella F, Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 2007;51:774-777.
43. Simonitsch-Klupp I, Hauser I, Ott G, et al. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 2004;18:146-155.
44. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005;18:806-815.
45. Serrano D, Carrion R, Balsalobre R et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 2005;33:487-494.
46. Re A, Cattaneo C, Michieli M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003;21:4423-4427.
47. Miralles P, Berenguer J, Ribera JM, et al. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 2007;44:167-173.
48. Cioc AM, Allen C, Kalmar JR, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004;28:41-46.
49. Deloose ST, Smit LA, Pals FT, et al. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005;19:851-855.
50. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: An aggressive Epstein-Barr virus-associated extramedullar plasmacytic neoplasm. Am J Surg Pathol 2005;29:1633-1641.
51. Nasta SD, Carrum GM, Shahab I, et al. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 2002;43:423-426.